HKPD
Cellyan Biotechnology Ltd.
NASDAQ · Healthcare · Medical - Pharmaceuticals · HK
$1.85
−4.64%Oct 21, 2026, 12:00 UTC
Cellyan Biotechnology announced a 1-for-20 reverse stock split of its Class A and Class B ordinary shares, effective at the market opening on October 26, 2026.
Source: